
Affidea accelerates its UK growth through strategic partnership with LIPS Healthcare
23.7.2026 18:27:14 CEST | GlobeNewswire by notified | Press release
LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- Affidea, the pan-European provider of community-based clinics, advanced diagnostics, and specialist private healthcare services, today announces a strategic partnership with LIPS Healthcare (London International Patient Services), the UK’s largest private consultant-led multi-specialty group. LIPS Healthcare’s strong clinical reputation, premium London presence and entrepreneurial medical culture make it a natural partner for Affidea as the Group brings its pan-European expertise in out-of-hospital care to the UK market.
As part of this partnership, Affidea will co-invest alongside LIPS Healthcare in a state-of-the-art 40,000 sq ft multi-specialty clinic, located on Prince of Wales Drive, due to break ground later this year, as well as in the extension of the existing Battersea Power Station Clinic. This will enable the business to expand its footprint, strengthen its diagnostic and treatment capabilities, and continue building an ecosystem where leading consultants can collaborate, innovate and continue delivering high-quality care for patients. Affidea’s investment marks an important step in its UK growth strategy, strengthening its presence in one of Europe’s most dynamic private healthcare markets.
Together, Affidea and LIPS Healthcare will create a platform for future growth in Southwest London, combining LIPS’s established consultant-led model and strong clinical reputation with Affidea’s European expertise in building and scaling high-quality, patient-centred, community-based healthcare services. With a network of more than 420 centres in 14 countries, Affidea will bring international know-how, operational capabilities and growth expertise to support LIPS Healthcare’s expansion, while preserving the clinical culture and entrepreneurial spirit that have shaped its success.
Founded in 2016 by orthopaedic consultants Paul Culpan and Ibraheim El-Daly, LIPS Healthcare has grown into the UK’s largest private multi-specialty group, bringing together more than 170 teaching hospital consultants across over 25 specialities. Headquartered at Battersea Power Station, LIPS provides patients with access to a broad range of services, including GP care, diagnostics, radiology, cardiology, dermatology, gynaecology, fertility, plastic surgery, paediatrics, urgent care and other specialist services.
The announcement follows Affidea’s recent UK investments, including the opening of diagnostic clinics in Whitstable, Kent and St. Asaph, North Wales, alongside the development of its new outpatient & ambulatory surgical centre in Wimbledon, located within a major retail destination and due to open in autumn 2026. Together, with the strategic co-investment in LIPS Healthcare, these investments underline Affidea’s long-term commitment to the UK market and its ambition to expand access to high-quality, community-based private healthcare in locations that are convenient and accessible for patients.
Quotes
“The UK private healthcare market is evolving rapidly, with growing demand for high-quality outpatient care delivered in more convenient and accessible settings. Our partnership with LIPS Healthcare gives Affidea a strong platform to help support that evolution. LIPS has built an impressive consultant-led model in London, with a reputation for clinical excellence and patient experience. By combining this with Affidea’s expertise in out-of-hospital scalable care models, we can support the next stage of LIPS’s growth and expand access to high-quality, patient-centred care across London and, over time, the wider UK market.”
— Barry Downes, CEO Affidea UK & Ireland
“Ten years ago, we set out to build something different, a home for medicine’s best minds, where consultants could lead, innovate, and genuinely shape the care they deliver. What we have built since then has exceeded every expectation. This partnership with Affidea is not the end of that journey. It is the moment that allows us to shift into higher gear. Affidea didn’t just believe in LIPS. They understood us. That trust means everything to me, to Paul, and to every consultant who is part of this organisation.”
— Ibraheim El-Daly, Founder & Managing Director, LIPS Healthcare
“Over the past years, we have built a strong track record in expanding access to exceptional care, delivered in an out-of-hospital setting across multiple markets, always with a focus on quality, patient experience and clinical governance. LIPS Healthcare represents a highly credible consultant-led platform in the UK, with a model that aligns closely with our vision for the future of outpatient healthcare. This investment strengthens our European footprint and marks an important new chapter for Affidea in the UK, one of Europe’s most dynamic healthcare markets.”
— Dr Charles Niehaus, Executive Director, Affidea Group
“In ten years of building LIPS, the question I’ve always asked is are we doing right for our patients and our doctors? This partnership allows us to answer that question with even greater confidence. Affidea brings world-class infrastructure, deep expertise, and a genuine belief in what we are building. Together, we have the platform to take LIPS further and faster than we could have gone alone — and to do it without compromising a single one of the values that got us here.”
— Paul Culpan, Founder & CEO, LIPS Healthcare
About LIPS Healthcare
Founded in 2016, LIPS Healthcare is the UK’s largest private multi-specialty group. Now headquartered at Battersea Power Station, London, LIPS has over 170 teaching hospital consultants across 25+ specialties, treating more than 70,000 patients annually, offering same-day appointments with no referral required. LIPS Healthcare partners with all leading insurers and embassies, offering care across GP, Dental, Physiotherapy, Aesthetics, Radiology, Cardiology, Dermatology, Gynaecology, Fertility, Plastic Surgery, Sexual Health, Urgent Care, Paediatrics and more. LIPS Healthcare is rated 4.8 out of 5 across patient review platforms with over 5000 reviews.
About Affidea
Affidea is Europe’s largest network of community-based polyclinics, advanced diagnostics and Centres of Excellence specialised in oncology, orthopaedics and neurology. Founded in 1991, the company operates approximately 420 centres across 14 countries and supports more than 15 million patients every year with accessible, high-quality healthcare delivered close to where they live and work.
In the UK, Affidea is present through its Fortius Clinic Centres of Excellence, now expanding its outpatient healthcare presence through the development of the new Affidea Wimbledon outpatient clinic, located in a major retail destination and expected to open in autumn 2026, and through its strategic minority investment in LIPS Healthcare. Together, these initiatives reflect Affidea’s long-term commitment to the UK market and its ambition to bring its European expertise in community-based care, to patients across London and, over time, the wider UK. Affidea is majority-owned by Groupe Bruxelles Lambert (GBL), a leading investment holding company, focused on long-term value-creation with a stable and supportive family shareholder base.
Media Enquiries
Mine Sino | Commercial and Partnerships | mine.sino@lips.org.uk
Oana Dumitroiu | SVP Marketing & Communication, Affidea Group | oana.dumitroiu@affidea.com
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/a80266b9-b88e-415b-b094-f4468416a7be
https://www.globenewswire.com/NewsRoom/AttachmentNg/ebf365b6-37f8-4704-9634-5f48c0f8f2e6
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Iveco Group signs a 150 million euro term loan facility with Cassa Depositi e Prestiti to support investments in research, development and innovation11.6.2024 12:00:00 CEST | Press release
Turin, 11th June 2024. Iveco Group N.V. (EXM: IVG), a global automotive leader active in the Commercial & Specialty Vehicles, Powertrain and related Financial Services arenas, has successfully signed a term loan facility of 150 million euros with Cassa Depositi e Prestiti (CDP), for the creation of new projects in Italy dedicated to research, development and innovation. In detail, through the resources made available by CDP, Iveco Group will develop innovative technologies and architectures in the field of electric propulsion and further develop solutions for autonomous driving, digitalisation and vehicle connectivity aimed at increasing efficiency, safety, driving comfort and productivity. The financed investments, which will have a 5-year amortising profile, will be made by Iveco Group in Italy by the end of 2025. Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a
DSV, 1115 - SHARE BUYBACK IN DSV A/S11.6.2024 11:22:17 CEST | Press release
Company Announcement No. 1115 On 24 April 2024, we initiated a share buyback programme, as described in Company Announcement No. 1104. According to the programme, the company will in the period from 24 April 2024 until 23 July 2024 purchase own shares up to a maximum value of DKK 1,000 million, and no more than 1,700,000 shares, corresponding to 0.79% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save for the rules on share buyback programmes set out in MAR article 5) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. Trading dayNumber of shares bought backAverage transaction priceAmount DKKAccumulated trading for days 1-25478,1001,023.01489,100,86026:3 June 20247,0001,050.597,354,13027:4 June 20245,0001,055.705,278,50028:6 June20243,0001,096.273,288,81029:7 June 20244,0001,106.174,424,68
Landsbankinn hf.: Offering of covered bonds11.6.2024 11:16:36 CEST | Press release
Landsbankinn will offer covered bonds for sale via auction held on Thursday 13 June at 15:00. An inflation-linked series, LBANK CBI 30, will be offered for sale. In connection with the auction, a covered bond exchange offering will take place, where holders of the inflation-linked series LBANK CBI 24 can sell the covered bonds in the series against covered bonds bought in the above-mentioned auction. The clean price of the bonds is predefined at 99,594. Expected settlement date is 20 June 2024. Covered bonds issued by Landsbankinn are rated A+ with stable outlook by S&P Global Ratings. Landsbankinn Capital Markets will manage the auction. For further information, please call +354 410 7330 or email verdbrefamidlun@landsbankinn.is.
Relay42 unlocks customer intelligence with a new insights and reporting module, powered by Amazon QuickSight11.6.2024 11:00:00 CEST | Press release
AMSTERDAM, June 11, 2024 (GLOBE NEWSWIRE) -- Relay42, a leading European Customer Data Platform (CDP), is leveraging Amazon QuickSight to power its new real-time customer intelligence, reporting, and dashboard module. Harnessing the breadth and quality of customer data, the new Insights module empowers marketing teams to dive deep into customer behaviors and gain invaluable insights into the performance of their marketing programs across all online, offline, paid, and owned marketing channels. Preview of the Relay42 Insights module, in pre-beta version Key capabilities of the Relay42 Insights module include: Deep insights into customer behaviors: With the Relay42 Insights module, marketers can ask unlimited questions about their data and gain a deeper understanding of how to serve their customers more effectively. Simplicity with AI-powered querying: Marketers can use artificial intelligence to query their data using natural language search, reducing the reliance on data scientists. Us
Metasphere Labs Announces X Spaces Event on the Topic of Green Bitcoin Mining and Sound Money for Sustainability11.6.2024 10:30:00 CEST | Press release
VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere Labs" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is thrilled to announce an engaging Twitter Spaces event on Green Bitcoin mining, energy markets, and sustainability on July 3, 2024 at 2 p.m. ET. Follow us on X at MetasphereLabs for updates and to join the event. What We'll Discuss Bitcoin Mining Basics: Understand the fundamentals of Bitcoin mining.Energy Market Dynamics: Explore how Bitcoin mining interacts with energy markets.Sustainable Innovations: Learn about our efforts to promote sustainability in Bitcoin mining.Sound Money: Discover how tamper-proof currency can enhance stability.Efficient Payment Rails: See how fast, neutral payment systems support humanitarian projects.Carbon Footprint: Compare Bitcoin's environmental impact with traditional banking. "We're excited to host this event and dive into the critical topics of Bitcoin